Rutgers Robert Wood Johnson Medical School (RWJMS) is projected to receive approximately $30 million, establishing a critical partnership with the larger National Institutes of Health-funded RECOVER initiative to study long-term and delayed impacts of COVID-19 in children and lead a national collaboration with the potential to recruit from any state to investigate these outcomes. Impacts of infection with the virus SARS-CoV-2 that present or persist more than 30 days are collectively referred to as post-acute sequelae of COVID-19 (PASC). Among the first PASC recognized is Multisystem Inflammatory Syndrome in Children (MIS-C), a severe acute inflammatory illness, which typically begins unexpectedly about a month after the initial infection. Children with MIS-C have fever and other symptoms that may include inflammation of the gastrointestinal tract, circulatory system and skin that sometimes mimic another rare illness, Kawasaki’s Disease. Beyond MIS-C, children are also susceptible to what is commonly referred to as “long COVID.” A team of researchers at Rutgers have studied COVID-19 and MIS-C from shortly after it was first described in the United States. “Children and adolescents are susceptible to long-term symptoms. Some have brain fog. READ MORE







